An update from Sol-Gel Technologies ( (SLGL) ) is now available.
On April 1, 2025, Sol-Gel Technologies Ltd. held a Special Meeting of Shareholders where two key resolutions were approved. The shareholders agreed to a reverse share split of the company’s ordinary shares, with the final ratio to be determined by the Board of Directors within the next 12 months. Additionally, the renewal of an updated Compensation Policy for the company’s officers and directors was approved for another three-year period, aligning with the Israeli Companies Law requirements. These decisions are expected to impact the company’s financial structure and governance, potentially influencing its market positioning and stakeholder relations.
More about Sol-Gel Technologies
Sol-Gel Technologies Ltd. operates in the pharmaceutical industry, focusing on the development and commercialization of topical dermatological drugs. The company is based in Ness Ziona, Israel, and is known for its innovative approach to drug delivery systems.
YTD Price Performance: -49.02%
Average Trading Volume: 145,473
Technical Sentiment Signal: Strong Buy
Current Market Cap: $14.49M
For a thorough assessment of SLGL stock, go to TipRanks’ Stock Analysis page.